[go: up one dir, main page]

WO2001050127A3 - Screening using biological target molecules with metal-ion binding sites - Google Patents

Screening using biological target molecules with metal-ion binding sites Download PDF

Info

Publication number
WO2001050127A3
WO2001050127A3 PCT/EP2000/013389 EP0013389W WO0150127A3 WO 2001050127 A3 WO2001050127 A3 WO 2001050127A3 EP 0013389 W EP0013389 W EP 0013389W WO 0150127 A3 WO0150127 A3 WO 0150127A3
Authority
WO
WIPO (PCT)
Prior art keywords
biological target
metal ion
ion binding
compounds
binding site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/013389
Other languages
French (fr)
Other versions
WO2001050127A8 (en
WO2001050127A9 (en
WO2001050127A2 (en
Inventor
Christian E Elling
Lars Ole Gerlach
Lange Birgitte Holst
Jan Torleif Pedersen
Thue W Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
7TM Pharma AS
Original Assignee
7TM Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 7TM Pharma AS filed Critical 7TM Pharma AS
Priority to CA002395999A priority Critical patent/CA2395999A1/en
Priority to EP00993741A priority patent/EP1242824A2/en
Priority to AU28449/01A priority patent/AU2844901A/en
Publication of WO2001050127A2 publication Critical patent/WO2001050127A2/en
Priority to AU2002215888A priority patent/AU2002215888A1/en
Priority to PCT/DK2001/000867 priority patent/WO2002054077A2/en
Publication of WO2001050127A3 publication Critical patent/WO2001050127A3/en
Anticipated expiration legal-status Critical
Publication of WO2001050127A9 publication Critical patent/WO2001050127A9/en
Publication of WO2001050127A8 publication Critical patent/WO2001050127A8/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides a molecular approach for rapidly and selectively identifying small organic molecule ligands, i.e. compounds, that are capable of interacting with and binding to specific sites on biological target molecules. The methods of the present invention are applicable to any biological target molecule that has or can be manipulated to have a metal ion binding site. A very interesting group of molecules are membrane proteins such as 7TM transmembrane proteins. The methods described herein make it possible to construct and screen libraries of compounds specifically directed against predetermined epitopes on the biological target molecules. The compounds are initially constructed to be bi-functional, i.e. having both a metal ion binding moiety enabling them to bind to a natural or artificial metal ion binding site, and a variable moiety, which is varied chemically to probe for interactions with specific parts of the biological target adjacent to the metal ion binding site. Compounds may subsequently be further modified to bind to the unmodified biological target molecule without help of the bridging metal ion.
PCT/EP2000/013389 1999-12-30 2000-12-29 Screening using biological target molecules with metal-ion binding sites Ceased WO2001050127A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA002395999A CA2395999A1 (en) 1999-12-30 2000-12-29 Screening using biological target molecules with metal-ion binding sites
EP00993741A EP1242824A2 (en) 1999-12-30 2000-12-29 Screening using biological target molecules with metal-ion binding sites
AU28449/01A AU2844901A (en) 1999-12-30 2000-12-29 A method of identifying ligands of biological target molecules
AU2002215888A AU2002215888A1 (en) 2000-12-29 2001-12-21 Validating biological molecules as drug targets by metal-ion chelates in animal test models
PCT/DK2001/000867 WO2002054077A2 (en) 2000-12-29 2001-12-21 Validating biological molecules as drug targets by metal-ion chelates in animal test models

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
DKPA199901879 1999-12-30
DKPA199901880 1999-12-30
DK199901879 1999-12-30
DK199901880 1999-12-30
US17599400P 2000-01-11 2000-01-11
US17540100P 2000-01-11 2000-01-11
US60/175,994 2000-01-11
US60/175,401 2000-01-11
DKPA200000705 2000-04-28
DK200000705 2000-04-28
US20299000P 2000-05-09 2000-05-09
US60/202,990 2000-05-09

Publications (4)

Publication Number Publication Date
WO2001050127A2 WO2001050127A2 (en) 2001-07-12
WO2001050127A3 true WO2001050127A3 (en) 2002-01-31
WO2001050127A9 WO2001050127A9 (en) 2002-09-12
WO2001050127A8 WO2001050127A8 (en) 2004-02-19

Family

ID=27545201

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/013389 Ceased WO2001050127A2 (en) 1999-12-30 2000-12-29 Screening using biological target molecules with metal-ion binding sites

Country Status (4)

Country Link
EP (1) EP1242824A2 (en)
AU (1) AU2844901A (en)
CA (1) CA2395999A1 (en)
WO (1) WO2001050127A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003008A1 (en) * 2001-06-29 2003-01-09 7Tm Pharma A/S Chemical libraries useful for drug discovery processes
WO2003003009A1 (en) * 2001-06-29 2003-01-09 7Tm Pharma A/S Use of metal-ion chelates in validating biological molecules as drug targets in test animal models
WO2003055914A2 (en) * 2001-12-21 2003-07-10 7Tm Pharma A/S Modified receptors for the discovery of therapeutic ligands
WO2003055477A1 (en) * 2001-12-21 2003-07-10 7Tm Pharma A/S Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
CN110390997B (en) * 2019-07-17 2023-05-30 成都火石创造科技有限公司 Chemical molecular formula splicing method
US20230226214A1 (en) * 2020-06-24 2023-07-20 Lycia Therapeutics, Inc. Bifunctional bridging compositions for viral transduction
CN117957020A (en) 2021-07-14 2024-04-30 利西亚治疗公司 ASGPR cell surface receptor binding compounds and conjugates

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040293A1 (en) * 1995-06-07 1996-12-19 Rhomed Incorporated Structurally determined metallo-constructs and applications
WO1996041169A1 (en) * 1995-06-07 1996-12-19 Praecis Pharmaceuticals Incorporated Functional bioassay for g-protein coupled receptor agonists and antagonists
WO1998012156A1 (en) * 1996-09-20 1998-03-26 President And Fellows Of Harvard College Combinatorial approach for generating novel coordination complexes
WO1999022733A1 (en) * 1997-10-31 1999-05-14 Smithkline Beecham Corporation Novel metal complexes
WO2000051632A2 (en) * 1999-03-03 2000-09-08 Konrad Beyreuther COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE
WO2001013112A1 (en) * 1999-08-12 2001-02-22 Palatin Technologies, Inc. Melanocortin metallopeptide constructs, combinatorial libraries and applications

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040293A1 (en) * 1995-06-07 1996-12-19 Rhomed Incorporated Structurally determined metallo-constructs and applications
WO1996041169A1 (en) * 1995-06-07 1996-12-19 Praecis Pharmaceuticals Incorporated Functional bioassay for g-protein coupled receptor agonists and antagonists
WO1998012156A1 (en) * 1996-09-20 1998-03-26 President And Fellows Of Harvard College Combinatorial approach for generating novel coordination complexes
WO1999022733A1 (en) * 1997-10-31 1999-05-14 Smithkline Beecham Corporation Novel metal complexes
WO2000051632A2 (en) * 1999-03-03 2000-09-08 Konrad Beyreuther COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE
WO2001013112A1 (en) * 1999-08-12 2001-02-22 Palatin Technologies, Inc. Melanocortin metallopeptide constructs, combinatorial libraries and applications

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ELLING CHRISTIAN E ET AL: "Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering.", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 15, no. 22, 1996, pages 6213 - 6219, XP002174723, ISSN: 0261-4189 *
ELLING CHRISTIAN E ET AL: "Conversion of agonist site to metal-ion chelator site in the beta2-adrenergic receptor.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 96, no. 22, 26 October 1999 (1999-10-26), Oct. 26, 1999, pages 12322 - 12327, XP002174721, ISSN: 0027-8424 *
ELLING CHRISTIAN E ET AL: "Disulfide bridge engineering in the tachykinin NK1 receptor.", BIOCHEMISTRY, vol. 39, no. 4, 1 February 2000 (2000-02-01), pages 667 - 675, XP002174724, ISSN: 0006-2960 *
NORREGAARD LENE ET AL: "Delineation of an endogenous zinc-binding site in the human dopamine transporter.", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 17, no. 15, 3 August 1998 (1998-08-03), pages 4266 - 4273, XP002174722, ISSN: 0261-4189 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9096652B2 (en) 2008-05-13 2015-08-04 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Also Published As

Publication number Publication date
AU2844901A (en) 2001-07-16
WO2001050127A8 (en) 2004-02-19
EP1242824A2 (en) 2002-09-25
WO2001050127A9 (en) 2002-09-12
CA2395999A1 (en) 2001-07-12
WO2001050127A2 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
ATE420953T1 (en) LIBRARIES OF HUMAN ANTIBODIES POLYPEPTIDES
JP2002541435A5 (en)
WO2006002382A3 (en) Arrays with cleavable linkers
WO2004077062B1 (en) Method for selecting a candidate drug compound
WO2004062553A3 (en) Affinity screening using “one-bead-one-compound” libraries
WO1997049805A3 (en) Recognition molecules interacting specifically with the active site or cleft of a target molecule
DK0839152T3 (en) Combinatorial libraries of labeled biochemical compounds and processes for their preparation
DK1124568T3 (en) Polyspecific Binding Molecules and Uses thereof
CA2497496A1 (en) In vitro peptide expression library
PT1007654E (en) PROTEIN EXPRESSION LIBRARY OR IN VITRO PEPTIDE
WO2003061570A3 (en) Engineered binding proteins
WO2001050127A8 (en) Screening using biological target molecules with metal-ion binding sites
Sawyer et al. Hydrogen bond surrogate stabilization of β-hairpins
Mahon et al. Templation-induced re-equilibration in polymer-scaffolded dynamic combinatorial libraries leads to enhancements in binding affinities
CN105277712B (en) A kind of method for identifying the modification of lysine ε amino side chains monomethylation
WO2004097041A3 (en) Screening method for binding molecules
EP3300739A3 (en) Antibodies and related molecules that bind to 161p2f10b proteins
WO2008094205A3 (en) A mild chemically cleavable linker system
WO1998016661A3 (en) Morphatides: novel shape and structure libraries
AU5601896A (en) Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses
AU2002218123A1 (en) Method of selection, by two-dimensional separation, of nucleic acids that bind to a target with high affinity
WO2007026972A3 (en) Binding protein molecule
EA199800843A1 (en) COMPUTER METHOD FOR CREATING CHEMICAL STRUCTURES WITH GENERAL FUNCTIONAL CHARACTERISTICS
Marquardt et al. A synthetic camel anti‐lysozyme peptide antibody (peptibody) with flexible loop structure identified by high‐resolution affinity mass spectrometry
WO2006073971A3 (en) Binding protein with a scaffold for varying specificity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000993741

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2395999

Country of ref document: CA

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 10, 18, 24, 33, 38, 40, 49, 51, 56, 57, 59 AND 61, DESCRIPTION, REPLACED BY NEW PAGES 10, 18, 24, 33, 38, 40, 49, 51, 56, 57, 59 AND 61; PAGES 70 AND 79, CLAIMS, REPLACED BY NEW PAGES 70 AND 79; PAGES 1/29-29/29, DRAWINGS, REPLACED BY NEW PAGES 1/29-29/29; AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY

WWP Wipo information: published in national office

Ref document number: 2000993741

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 28/2001 DUE TO A TECHNICAL PROBLEMAT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING UNDER (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION DUE TO A TECHNICAL PROBLEMAT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING UNDER (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000993741

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)